To investigate whether down-regulation of the SGK1 transcript could be reversed in colorectal cancer cell lines, we treated the cells with serum and the corticosteroid dexamethasone, both of which have been previously reported to increase transcription of Sgk1[5], [15]. Here, SGK1 is linked to colorectal cancer.